| 'Unexplained death'from malaria tropica mistaken for viral haemorrhagic fever. P Heyman, J Meulen, M Roman, H Schmitz, F Heyvaert, P Racz, ... | 4 | 1999 |
| 1008P CytoTIL15: A novel TIL therapy for melanoma with superior potency and enhanced persistence without IL2 to improve safety & efficacy and expand patient eligibility M Khattar, R Burga, K Pedro, C Foley, S Lajoie, AV Ocando, J Tremblay, ... Annals of Oncology 32, S852, 2021 | 1 | 2021 |
| 166 Genetically engineered tumor-infiltrating lymphocytes (cytoTIL15) exhibit IL-2-independent persistence and anti-tumor efficacy against melanoma in vivo R Burga, M Khattar, S Lajoie, K Pedro, C Foley, AV Ocando, J Tremblay, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 3 | 2021 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 12 | 2016 |
| A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs JM Odegard, PA Flynn, DJ Campbell, SH Robbins, L Dong, K Wang, ... Vaccine 34 (1), 101-109, 2016 | 46 | 2016 |
| A phase 1b study evaluating the safety, tolerability, and immunogenicity of CMB305, a lentiviral-based prime-boost vaccine regimen, in patients with locally advanced, relapsed … N Somaiah, SP Chawla, MS Block, JC Morris, K Do, JW Kim, M Druta, ... Oncoimmunology 9 (1), 1847846, 2020 | 29 | 2020 |
| A rapid and improved method to generate recombinant dengue virus vaccine candidates D Govindarajan, L Guan, S Meschino, A Fridman, A Bagchi, I Pak, ... PLoS One 11 (3), e0152209, 2016 | 9 | 2016 |
| A rapid and improved method to generate recombinant dengue virus vaccine candidates. DG Dhanasekaran Govindarajan, GLM Guan LiMing, S Meschino, ... | | 2016 |
| A" prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells TC Albershardt, AJ Parsons, P Flynn, P Berglund, J ter Meulen Journal for ImmunoTherapy of Cancer 2 (Suppl 3), P190, 2014 | | 2014 |
| Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge C Meyer, F Engelmann, N Arnold, DL Krah, J ter Meulen, K Haberthur, ... Journal of virology 89 (3), 1781-1793, 2015 | 13 | 2015 |
| Abstract LB065: Tumor-infiltrating lymphocytes (TIL) engineered with regulatable membrane-bound IL15 (mbIL15) and LIGHT (TNFSF14) show enhanced efficacy in fibroblast … B Koscso, Z Ao, C Passaro, N Shah, N Ly, P Timpug, BA Aksoy, D Sun, ... Cancer Research 84 (7_Supplement), LB065-LB065, 2024 | | 2024 |
| Abstract LB072: Tumor-infiltrating lymphocytes (TIL) engineered with membrane-bound IL15 (cytoTIL15 cells) exhibit pharmacologically regulatable signal transduction in cis and … R Burga, G Kulkarni, Z Ao, DK Sethi, J ter Meulen, M Ols Cancer Research 84 (7_Supplement), LB072-LB072, 2024 | | 2024 |
| Abstract LB093: Engineering tumor infiltrating lymphocytes from sarcoma and colorectal tumors with membrane bound IL-15 for IL-2 independent expansion and enhanced cytotoxicity … Z Ao, C Passaro, BA Aksoy, B Koscso, R Burga, K Pedro, N Ly, N Shah, ... Cancer Research 83 (8_Supplement), LB093-LB093, 2023 | | 2023 |
| Abstract LB096: IL15-engineered tumor infiltrating lymphocytes (cytoTIL15TM) exhibit activity against autologous tumor cells from multiple solid tumor indications … KD Pedro, R Burga, AV Ocando, M Langley, G Kulkarni, Z Ao, B Primack, ... Cancer Research 83 (8_Supplement), LB096-LB096, 2023 | 1 | 2023 |
| Abstract LB101: Novel Drug-responsive domain (DRD)-based regulation technology enables tightly controlled activity of potent membrane-bound IL12 in adoptive cell therapies SG Smith, JA Storer, D Sun, DJ Li, B Primack, T Ross, S LaJoie, ... Cancer Research 82 (12_Supplement), LB101-LB101, 2022 | | 2022 |
| Abstract LB212: Allogeneic, IL-2-independent tumor-infiltrating lymphocytes expressing membrane-bound IL-15 (cytoTIL15࣪) eradicate tumors in a melanoma PDX model through … JH Tchaicha, S Lajoie, R Burga, T Ross, B Primack, M Langley, V Young, ... Cancer Research 82 (12_Supplement), LB212-LB212, 2022 | 1 | 2022 |
| Activation of the cytokine network and unfavorable outcome in patients with yellow fever J ter Meulen, M Sakho, K Koulemou, NF Magassouba, A Bah, W Preiser, ... The Journal of infectious diseases 190 (10), 1821-1827, 2004 | 125 | 2004 |
| Administration of tumor infiltrating lymphocytes with membrane bound interleukin 15 to treat cancer M Khattar, S Subramanian, R Burga, ML Ols, J Ter Meulen, K Pedro, ... US Patent App. 18/501,621, 2024 | | 2024 |
| Administration of tumor infiltrating lymphocytes with membrane bound interleukin 15 to treat cancer M Khattar, S Subramanian, R Burga, ML Ols, J Ter Meulen, K Pedro, ... US Patent App. 17/577,940, 2022 | | 2022 |
| AG Dalgleish, London, UK PV Coyle, D Katzenstein, J ter Meulen, A Billiau, CH von Bonsdorff, ... | | |
